Target Promising in Asthma and Cancer – Drug Discovery & Development


Drug Discovery & Development

Target Promising in Asthma and Cancer
Drug Discovery & Development
Mice without the enzyme SKG1 were resistant to dust mite-induced asthma. In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target …
Novel Molecular Target for Asthma and Cancer IdentifiedGenetic Engineering News
`Immune system` regulating enzyme can help treat asthma and cancerDaily News & Analysis

all 13 news articles »

View full post on asthma – Google News

Enzyme Revealed As Promising Target To Treat Asthma And Cancer – RedOrbit


Counsel & Heal

Enzyme Revealed As Promising Target To Treat Asthma And Cancer
RedOrbit
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
Novel Molecular Target for Asthma and Cancer IdentifiedGenetic Engineering News
`Immune system` regulating enzyme can help treat asthma and cancerDaily News & Analysis
Researchers Discover Enzyme That Could Be Promising Target To Treat Asthma Counsel & Heal

all 12 news articles »

View full post on asthma – Google News

Enzyme Revealed as Promising Target to Treat Asthma and Cancer – Newswise (press release)


ANINEWS

Enzyme Revealed as Promising Target to Treat Asthma and Cancer
Newswise (press release)
Newswise — In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain
`Immune system` regulating enzyme can help treat asthma and cancerDaily News & Analysis

all 6 news articles »

View full post on asthma – Google News

Enzyme revealed as promising target to treat asthma and cancer – EurekAlert (press release)

Enzyme revealed as promising target to treat asthma and cancer
EurekAlert (press release)
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.

and more »

View full post on asthma – Google News

Cancer Research UK to Repurpose AstraZeneca Asthma Drug for Kidney Cancer – Genetic Engineering News


Drug Discovery & Development

Cancer Research UK to Repurpose AstraZeneca Asthma Drug for Kidney Cancer
Genetic Engineering News
AZD2098 was originally designed to treat asthma. CRUK says this deal with AZ will enable its Drug Development Office (DDO) to complete preclinical development and carry out early clinical trials of the compound to see if it can benefit kidney cancer
Cancer Research UK, AstraZeneca To Repurpose Asthma Drug for Kidney CancerDrug Discovery & Development

all 2 news articles »

View full post on asthma – Google News

Cancer Research UK, AstraZeneca To Repurpose Asthma Drug for Kidney Cancer – Drug Discovery & Development


Drug Discovery & Development

Cancer Research UK, AstraZeneca To Repurpose Asthma Drug for Kidney Cancer
Drug Discovery & Development
Cancer Research UK and Cancer Research Technology–the charity's development and commercialization arm–have reached an agreement with AstraZeneca to take AZD2098, an experimental drug originally designed for asthma, into a clinical trial to treat 
Cancer Research UK to Repurpose AstraZeneca Asthma Drug for Kidney CancerGenetic Engineering News

all 2 news articles »

View full post on asthma – Google News